Hyun-Soo Kim
Fortune : 43 M $ au 31/08/2026
Fortune : 43 M $ au 31/08/2026
Hyun-Soo Kim currently works at Pharmicell Co., Ltd., as Chairman & Chief Executive Officer from 2009.
Mr. Kim also formerly worked at FCB Twelve Co., Ltd., as Co-CEO, Director, Head-Research & Development from 2009 to 2011 and FCB-Pharmicell Co., Ltd., as Chief Executive Officer & Director from 2010 to 2011.
Mr. Kim received his undergraduate degree from Yonsei University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMICELL CO., LTD 8,85 % | 16/06/2026 | 5 309 547 ( 8,85 % ) | 43 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PHARMICELL CO., LTD. | Directeur Général | 19/08/2009 |
| Sociétés | Poste | Fin |
|---|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables Manufactures women's suits and coats | President | 06/10/2011 |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops adult cell stem therapy | President | 27/06/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables Manufactures women's suits and coats | Consumer Non-Durables |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops adult cell stem therapy | Commercial Services |
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmicell Co., Ltd.
Pharmicell Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops stem cell based pharmaceuticals and technologies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national